Mirus Bio Named a Top Workplace by the Wisconsin State Journal

Mirus Bio has been named a Top Workplace 2024 by Wisconsin State Journal Top Workplaces. This award is based solely on employee feedback collected from a survey administered by an external organization.
Mirus Bio Receives ISO 13485:2016 Certification

Mirus Bio Receives ISO 13485:2016 Certification Completion of this comprehensive certification process underscores the quality of the processes used to support the company’s GMP product portfolio MADISON, Wis., January 31, 2024 — Mirus Bio, a life sciences company developing innovative solutions for nucleic acid delivery to support cell and gene therapy production, biopharmaceutical manufacturing, and research applications, today […]
2021: Transfection platform for production of AAV and lentivirus at clinical and commercial scales
Transfection platform for production of AAV and lentivirus for research and preclinical applications
2015: Introduced platform for protein production in CHO cells

Sold in vivo siRNA delivery technology to Roche
Development of the first serum-compatible transfection reagent with TransIT®-LT1 Transfection reagent
1995: Mirus Bio founded
